Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep159 | Pituitary and Neuroendocrinology | ECE2024

Successful medical management of giant prolactinomas: a comprehensive case report

Monteiro Antunes Carolina , Guia Lopes Leonor , Sprovera Paula , Oliveira Margarida , Pimentel Bruna , Gama Catarina , Sousa Santos Francisco , Sequeira Duarte Joao

Introduction: Giant prolactinomas (diameter >4 cm) account for less than 5% of all prolactinomas and are usually associated with markedly elevated prolactin (PRL) levels. Despite their benign nature, these tumors can be invasive, potentially leading to mass effect symptoms in affected patients.Case Report: We report a case of a 40-year-old male admitted to the emergency department with a one-week history of headaches, right palpebral edema, and ptosi...

ea0090p708 | Pituitary and Neuroendocrinology | ECE2023

Congenital, isolated, and lifetime growth hormone deficiency provides superior cognitive performance in senescence

Batista Vanderlan O. , Kellner Michael , Salvatori Roberto , Oliveira Walter , Faro Andre , Santos Lucas B. , Melo Enaldo V. , Oliveira-Santos Alecia A. , Oliveira Carla R. P. , Almeida Viviane , Barros-Oliveira Cynthia S. , Santos Elenilde G. , Santana Nathalie O. , Villar-Gouy Keila R. , Leal Angela , Amorim Rivia S. , H. Aguiar-Oliveira Manuel

Mice with isolated GH deficiency (IGHD) due to GHRH receptor mutations live longer than their normal siblings with an extended healthspan, i.e., the period of life free from disabilities. Human IGHD individuals due to a mutation in the GHRH receptor gene from Itabaianinha, Brazil, has a normal lifespan with an extended healthspan (1). Our hypothesis is that their aging is accompanied by a delayed cognitive decline. Accordingly, we used the Literacy Independent Cognitive Assess...

ea0090ep706 | Pituitary and Neuroendocrinology | ECE2023

Translation into Portuguese and cultural adaptation of the Literacy Independent Cognitive Assessment

Santos Lucas B. , Kellner Michael , Oliveira Walter , Faro Andre , Oliveira Carla R P , Batista Vanderlan O , Oliveira-Santos Alecia A , de Brito Iris de Vita Alves , Almeida Viviane , Villar-Gouy Keila R , Leal Angela , Amorim Rivia S , Melo Enaldo V , Santos Elenilde G , Salvatori Roberto , Aguiar-Oliveira Manuel H.

Population aging has become a universal worldwide phenomenon. Developing countries (such as Portuguese-speaking countries, with a high rate of illiteracy) will see the greatest increase in the absolute number of elderly people, and dementia disorders will pose enormous challenges to public health in these countries. Although the decline in GH secretion with age has been associated with deleterious conditions of aging, our understanding is the opposite, that the decline in GH s...

ea0081oc14.2 | Oral Communications 14: Late Breaking | ECE2022

Peripheral facial paralysis as first manifestation of hypophysary glioma: a case report

Maria Telles Jessica , Boas Laura Vilas , Cardoso da Silva Thielsen , Andrusko dos Santos Gabrielle , Rosales Matheus Kowal , Melquiades da Rocha Bruno , Paulino Ribeiro Gama Mirnaluci

Introduction: Low-grade pituitary gliomas are extremely rare neoplasms, originating from the pituicytes of the posterior pituitary or infundibulum. The incidence of these tumors increases with age and peaks in the seventh decade of life. Gliomas are primary brain tumors of the supporting glial cells of the central nervous system, which derive from neuroglial stem cells or progenitor cells. They are responsible for nearly 30% of all primary brain tumors and 80% of all malignant...

ea0081p741 | Thyroid | ECE2022

Efficacy of radioactive iodine treatment in Graves Disease using a calculated 131I dose and predictive factors of success in a Portuguese cohort

Franco Sara , Teixeira Ferreira Rita , Cardoso Ferreira Ines , Quitalo Ana , Barbosa David , Manuel Costa Maria , Vara Luiz Henrique , Raimundo Luisa , Isabel Santos Ana

Aim: Dose corrected for thyroid gland size is one of the methods used to determine radioactive iodine (RAI) activity for patients with Graves disease (GD). This study was aimed to investigate the real-world success rate of this method and the predictors of success after first treatment.Methods: This is a retrospective study of 80 patients with GD treated between 2014 and 2020 in a tertiary referral hospital in Almada, Portugal. The successful group was d...

ea0081ep1186 | Late Breaking | ECE2022

Hypobetalipoproteinemia: case report and literature review

Rosales Matheus Kowal , Vilas Boas Laura , Silva Thielsen Cardoso da , Telles Jessica Maria , Santos Gabrielle Andrusko dos , Munoz Marcela Malinoski , Paulino Ribeiro Gama Mirnaluci

Introduction: Primary hypobetalipoproteinemia corresponds to a series of congenital disorders that have a variable incidence from 3.2% to less than 1 in 1 million, depending on the type of genetic mutation. The diseases that comprise it occur due to different types of mutations in genes that will encode important proteins at different stages of lipid metabolism. Individuals with determinant mutations of severe phenotypes, such as Bassen-Kornzweig syndrome, as known as Abetalip...

ea0084ps3-14-132 | Thyroid Cancer CLINICAL 2 | ETA2022

Efficacy and safety of lenvatinib in a cohort of well-differentiated advanced thyroid carcinomas

Damasio Ines , Maciel Joana , Figueiredo Ana , Simoes Helder , Nunes da Silva Tiago , Simoes-Pereira Joana , Horta Mariana , Santos Rita , Donato Sara , Leite Valeriano

Introduction: Treatment of differentiated thyroid carcinoma (DTC) remains a challenge in the setting of locally advanced or metastatic disease refractory to radiodine (RAI) therapy. SELECT trial demonstrated that Lenvatinib improved progression free survival (PFS) comparing to placebo.Objective: Our aim is to report the efficacy and safety of lenvatinib in our population with aggressive DTC.Methods: We retrospectively reviewed the ...

ea0090rc1.4 | Rapid Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2023

Angiotensin-converting enzyme in type II diabetes: effects of combined training on cardiovascular components and blood components

Matos Andreia , Gil Angela , Alonso Isanete , P. Magalhaes Joao , Santos Ana Carolina , Ribeiro Rogerio , F. Raposo Joao , B. Sardinha Luis , Bicho Manuel

Objectives: The angiotensin-converting enzyme (ACE1) gene is one of the most studied genes in the pathogenesis of type II diabetes (T2DM) and cardiovascular disease. However, in the context of exerciSemodels in T2DM, they are not yet fully understood. We intended to characterize the genetic profile of individuals with T2DM from an inter-individual point of view using prognostic markers and cardiovascular risk. On the other hand, relate it with the profile obtained wit...

ea0090ep595 | Endocrine-related Cancer | ECE2023

Immune checkpoint inhibitors induced endocrinopathies: a possible indicator of improved survival

Ornelas Mariana , Borges-Canha Marta , Gouveia Pedro , Maria Morna Ferreira Margarida , Resende Eduarda , Santos Sa Elena Maritza Pontes , Silvestre Abreu Francisco

Background: Immune checkpoint inhibitors (ICI) are an innovative oncologic therapy used in several types of solid and hematological neoplasms. This treatment enables the antitumoral immune system response and results in significant improvement of clinical outcomes and survival rate. However, endocrine related adverse effects (ERAE) have been related, with thyroid and pituitary dysfunction being the most common endocrine diseases described. An association between the surge of e...

ea0063oc4.1 | Thyroid 1 | ECE2019

Subclinical hypothyroidism troughout pregnancy in TPOAb positive pregnant women

Baraia-Etxaburu Astigarraga Marta , Pi Barrio Javier , Gundin Menendez Simon , Arrabal Alonso Angela , Ruiz Perez Enrique , Esparcia Arnedo Irene , Monroy Sanchez Jorge , Santos Mazo Estefania

Background and objective: According to recent studies, endocrine societies have modified the treatment criteria of subclinical gestational hypothyroidism, increasing TSH upper-limit value commonly set at 2.5 μU/ml to a new threshold set at 4 μU/ml. This change in criteria has responded to numerous studies which seem to indicate that the obstetrical complications do not generally increase despite this variation of the threshold TSH value. A further discussion lays now...